The designation will help facilitate the expeditious development of the VentFree muscle stimulator, which has the proposed indication of preventing breathing muscle atrophy and reducing the number of days of ventilator support in adults who require mechanical ventilation.
(PRWeb January 24, 2019)
Read the full story at https://www.prweb.com/releases/liberate_medicals_ventfree_muscle_stimulator_receives_breakthrough_device_designation_from_the_fda_to_reduce_mechanical_ventilation_duration/prweb16052781.htm
For more information, please visit
https://www.prweb.com/releases/liberate_[...]ion_duration/prweb16052781.htm